Gedera, Israel

Liora Shiftan

This inventor holds 1 USPTO granted patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2009.


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liora Shiftan: Innovator in Hyaluronidase Detection

Introduction

Liora Shiftan is a notable inventor based in Gedera, Israel. She has made significant contributions to the field of biochemistry, particularly in the detection of hyaluronidase activity. Her innovative work has led to the development of a unique composition that has practical applications in various scientific fields.

Latest Patents

Liora Shiftan holds a patent for her invention titled "Compositions for detecting hyaluronidase activity in situ and methods of utilizing same." This composition-of-matter comprises a chelator moiety-hyaluronan complex bound to a solid support. The patent outlines methods for in-situ assessing hyaluronidase activity using these compositions, showcasing her expertise in creating practical solutions for biochemical challenges. She has 1 patent to her name.

Career Highlights

Liora is currently associated with Yeda Research and Development Company Ltd., where she continues to push the boundaries of scientific research. Her work at Yeda has allowed her to collaborate with other talented researchers and contribute to advancements in her field.

Collaborations

One of her notable collaborators is Michal Neeman, who is also a prominent figure in the research community. Together, they work on projects that aim to enhance the understanding of hyaluronidase and its implications in various biological processes.

Conclusion

Liora Shiftan's innovative contributions to the detection of hyaluronidase activity highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also has the potential to impact various applications in biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…